Aimil Pharmaceuticals India
FDA import alert and refusal historyNew Delhi, IndiaFEI 3008640783
As of October 26, 2026, Aimil Pharmaceuticals India is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on October 8, 2026, most often for unapproved new drug (UNAPPROVED).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Cocculus · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Aimil Pharmaceuticals India
1 record, newest first. Each line links to the FDA page it came from.
2026
- Import refusalRefused, CocculusUNAPPROVEDEntry 1FX-1129280-3Source
Refusal charges, in plain English
- UNAPPROVED1 refused line
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Aimil Pharmaceuticals India
- Is Aimil Pharmaceuticals India on an FDA import alert?
- No listing for Aimil Pharmaceuticals India appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the India page.
- Has FDA refused shipments from Aimil Pharmaceuticals India?
- Yes. FDA refused 1 shipment line from Aimil Pharmaceuticals India on October 8, 2026. The most recent, on October 8, 2026, was cocculus, charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Aimil Pharmaceuticals India's shipments?
- The most frequent charge is UNAPPROVED (unapproved new drug, 1 line).
- What is Aimil Pharmaceuticals India's FEI number?
- Aimil Pharmaceuticals India's FDA Establishment Identifier (FEI) is 3008640783.
Buying from Aimil Pharmaceuticals India?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.